Ledger.Open graph →
SEC Form D · filed May 5, 2016

Acerus Pharmaceuticals Corp

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MISSISSAUGA, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Matthew K. Hawkins · MISSISSAUGA, Ontario, CanadaExecIan Ihnatowycz · MISSISSAUGA, Ontario, CanadaDirectorBorys K. Chabursky · MISSISSAUGA, Ontario, CanadaDirectorTom K. Rossi · MISSISSAUGA, Ontario, CanadaExec · DirectorJosef K. Vejvoda · MISSISSAUGA, Ontario, CanadaDirectorRolf K. Reininghaus · MISSISSAUGA, Ontario, CanadaDirectorJeffrey K. Sherman · MISSISSAUGA, Ontario, CanadaDirectorDr. Nathan K. Bryson · MISSISSAUGA, Ontario, CanadaExecDr. Michael K. Bumby · MISSISSAUGA, Ontario, CanadaExecStephen Gregory · MISSISSAUGA, Ontario, CanadaDirectorNorma Beauchamp · MISSISSAUGA, Ontario, CanadaDirectorMatthew K. Hawkins · MISSISSAUGA, Ontario, CanadaExecIan Ihnatowycz · Vancouver, British Columbia, CanadaDirectorBorys K. Chabursky · MISSISSAUGA, Ontario, CanadaDirectorRolf K. Reininghaus · MISSISSAUGA, Ontario, CanadaDirectorTom K. Rossi · MISSISSAUGA, Ontario, CanadaExec · DirectorJeffrey K. Sherman · MISSISSAUGA, Ontario, CanadaDirectorDr. Nathan K. Bryson · MISSISSAUGA, Ontario, CanadaExecDr. Michael K. Bumby · MISSISSAUGA, Ontario, CanadaExecStephen Gregory · MISSISSAUGA, Ontario, CanadaDirectorJosef K. Vejvoda · MISSISSAUGA, Ontario, CanadaDirectorNorma Beauchamp · MISSISSAUGA, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗